G740-1309 Screening compound: N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{3,7-dimethyl-4-oxo-2-phenyl-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl}butanamide

G740-1309 Screening compound: N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{3,7-dimethyl-4-oxo-2-phenyl-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl}butanamide
G740-1309 Screening compound: N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{3,7-dimethyl-4-oxo-2-phenyl-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl}butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G740-1309
N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{3,7-dimethyl-4-oxo-2-phenyl-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl}butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G740-1309

Molecular Formula

C26H36N6O2 (C26 H36 N6 O2)

Compound Name

N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{3,7-dimethyl-4-oxo-2-phenyl-2H,4H,5H-pyrazolo[3,4-d]pyridazin-5-yl}butanamide

IUPAC name

N-{2-[cyclohexyl(methyl)amino]ethyl}-2-{37-dimethyl-4-oxo-2-phenyl-2H4H5H-pyrazolo[34-d]pyridazin-5-yl}butanamide

SMILES

CCC(C(NCCN(C)C1CCCCC1)=O)N(C(c1c2C)=O)N=C(C)c1nn2-c1ccccc1

InChI

InChI=1S/C26H36N6O2/c1-5-22(25(33)27-16-17-30(4)20-12-8-6-9-13-20)32-26(34)23-19(3)31(21-14-10-7-11-15-21)29-24(23)18(2)28-32/h7,10-11,14-15,20,22H,5-6,8-9,12-13,16-17H2,1-4H3,(H,27,33)/t22-/m0/s1

InChI Key

RUQIIVCOLWISKI-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD27155221

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.61

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.571

Distribution Coefficient, logD

2.047

Water Solubility, LogSw

-3.70

Polar Surface Area

67.024

Acid Dissociation Constant (pKa)

13.97

Base Dissociation Constant (pKb)

8.91

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

53.80

G740-1309 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Immunological Library (6760 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G740-1309 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G740-1309?
Check Price and Availability of G740-1309, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G740-1309 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G740-1309
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G740-1309
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G740-1309 available by request